Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
3
75%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

completed375%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_2

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

NCT06722729
completedphase_2

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

NCT04867551
completedphase_2

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

NCT03845387
completedphase_1

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

NCT03068481

Clinical Trials (4)

Showing 4 of 4 trials
NCT06722729Phase 2

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Active Not Recruiting
NCT04867551Phase 2

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

Completed
NCT03845387Phase 2

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Completed
NCT03068481Phase 1

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4